Profitable Exits

Anybrain
Braga, Portugal
Co-investors: Trust Esport (France) and EggNest (Portugal)
Website: anybrain.gg

Anybrain developed a new AI-based solution for video game studios, allowing seamless player identification, fraud prevention, age control and fatigue tracking.

CellmAbs
Lisbon, Portugal
Co-investor: Portugal Ventures (Portugal)
Website: www.cellmabs.com

Developing monoclonal antibodies and adoptive T cell therapies as well as diagnostic devices for early detection of cancer in patients.



Active Portfolio

Adapttech
Birmingham, UK
Co-investor: Mercia Asset Management (UK)
Website: www.adapttech.eu

A new prosthetics fitting solution for lower limbs. The INSIGHT System combines a 3D scanner, a wearable device, and an iPad application to analyse the fitting of the residual limb-socket. The purpose of the technology is to improve the efficiency of the fitting process to rapidly deliver an ultra-comfortable and uniquely-fitted prosthesis for the patient.

Delox
Lisbon, Portugal
Co-investors: CaixaCapital (Portugal) and Kiilto Ventures (Finland)
Website: delox.pt

Developing a solid hydrogen-peroxide formulation ("dryVHP") suitable for building simple and affordable sterilization devices for descontamination of hospitals, laboratories and facilities in the food industry.



SolasCure
Cardiff, Wales
Co-investors: BRAIN (Germany), Development Bank of Wales and others
Website: solascure.com

Developing a new treatment for chronic wounds, with the potential to produce an effective, practical and easy to use new method of treating patients with wounds.

Vaxdyn
Seville, Spain
Co-investors: CARB-X (USA), Laboratorios Reig Jofré (Spain), Arquimea Group (Spain) and Botín Foundation (Spain)
Website: www.vaxdyn.com

Developing a new vaccine against drug-resistant bacteria.